▶ 調査レポート

少量非経口薬(SVP)の世界市場レポート2020

• 英文タイトル:Global Small Volume Parenterals (SVP) Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。少量非経口薬(SVP)の世界市場レポート2020 / Global Small Volume Parenterals (SVP) Sales Market Report 2020 / QY20ST-03112資料のイメージです。• レポートコード:QY20ST-03112
• 出版社/出版日:QYResearch / 2020年9月15日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、134ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療機器・消耗品
• 販売価格(消費税別)
  Single User¥560,000 (USD4,000)▷ お問い合わせ
  Multi User¥840,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,120,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の少量非経口薬(SVP)市場について種類別(アンプル、バイアル、プレフィルドシリンジ)、用途別(局所麻酔薬、ワクチン、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・少量非経口薬(SVP)市場の概要
・世界の主要地域別少量非経口薬(SVP)市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の少量非経口薬(SVP)市場規模2015-2026:種類別(アンプル、バイアル、プレフィルドシリンジ)
・世界の少量非経口薬(SVP)市場規模2015-2026:用途別(局所麻酔薬、ワクチン、その他)
・少量非経口薬(SVP)の北米市場規模2015-2020
・少量非経口薬(SVP)のヨーロッパ市場規模2015-2020
・少量非経口薬(SVP)の中国市場規模2015-2020
・少量非経口薬(SVP)の日本市場規模2015-2020
・少量非経口薬(SVP)の東南アジア市場規模2015-2020
・少量非経口薬(SVP)のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・少量非経口薬(SVP)の製造コスト分析
・販売チャネル、流通業者、顧客
・少量非経口薬(SVP)の市場動向・機会・課題
・調査の結論

Small volume parenteral (SVP) solutions are usually 100 ml or less and are packaged in different ways depending on the intended use. If the SVP is a liquid that is used primarily to deliver medications, it is packaged in a small plastic bag called a minibag of 50 – 100 ml (minibags look like small plastic LVP bags). SVPs can also be packaged as ampules, vials, and prefilled syringes. Liquid drugs are supplied in prefilled syringes, heat-sealed ampules, or in vials sealed with a rubber closure. Powdered drugs are supplied in vials and must be constituted (dissolved in a suitable liquid) before being added to any solution. SVPs packaged as ampules, vials, or prefilled syringes are typically added to a minibag or a LVP but they may also serve as the final container. The term admixture is used to denote a solution where such an additive has been added to a minibag or LVP.

Market Analysis and Insights: Global Small Volume Parenterals (SVP) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Small Volume Parenterals (SVP) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Small Volume Parenterals (SVP) industry.
Based on our recent survey, we have several different scenarios about the Small Volume Parenterals (SVP) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Small Volume Parenterals (SVP) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Small Volume Parenterals (SVP) Scope and Market Size
The global Small Volume Parenterals (SVP) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Small Volume Parenterals (SVP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Small Volume Parenterals (SVP) market is segmented into
Ampules
Vials
Prefilled Syringes

Segment by Application, the Small Volume Parenterals (SVP) market is segmented into
Local Anesthetics
Vaccines
Other

The Small Volume Parenterals (SVP) market is analysed and market size information is provided by regions (countries). Segment by Application, the Small Volume Parenterals (SVP) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Small Volume Parenterals (SVP) Market Share Analysis
Small Volume Parenterals (SVP) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Small Volume Parenterals (SVP) business, the date to enter into the Small Volume Parenterals (SVP) market, Small Volume Parenterals (SVP) product introduction, recent developments, etc.

The major vendors covered:
Allergan
Bayer
GSK
J&J
Pfizer
Teva
Novartis

レポート目次

1 Small Volume Parenterals (SVP) Market Overview
1.1 Small Volume Parenterals (SVP) Product Scope
1.2 Small Volume Parenterals (SVP) Segment by Type
1.2.1 Global Small Volume Parenterals (SVP) Sales by Type (2020-2026)
1.2.2 Ampules
1.2.3 Vials
1.2.4 Prefilled Syringes
1.3 Small Volume Parenterals (SVP) Segment by Application
1.3.1 Global Small Volume Parenterals (SVP) Sales Comparison by Application (2020-2026)
1.3.2 Local Anesthetics
1.3.3 Vaccines
1.3.4 Other
1.4 Small Volume Parenterals (SVP) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Small Volume Parenterals (SVP) Sales Growth Rate (2015-2026)
1.4.2 Global Small Volume Parenterals (SVP) Revenue and Growth Rate (2015-2026)
1.4.3 Global Small Volume Parenterals (SVP) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Small Volume Parenterals (SVP) Industry Impact
1.5.1 How the Covid-19 is Affecting the Small Volume Parenterals (SVP) Industry
1.5.1.1 Small Volume Parenterals (SVP) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Small Volume Parenterals (SVP) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Small Volume Parenterals (SVP) Players to Combat Covid-19 Impact

2 Small Volume Parenterals (SVP) Estimate and Forecast by Region
2.1 Global Small Volume Parenterals (SVP) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Small Volume Parenterals (SVP) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Small Volume Parenterals (SVP) Sales Market Share by Region (2015-2020)
2.2.2 Global Small Volume Parenterals (SVP) Revenue Market Share by Region (2015-2020)
2.3 Global Small Volume Parenterals (SVP) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Small Volume Parenterals (SVP) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Small Volume Parenterals (SVP) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Small Volume Parenterals (SVP) Estimates and Projections (2015-2026)
2.4.2 Europe Small Volume Parenterals (SVP) Estimates and Projections (2015-2026)
2.4.3 China Small Volume Parenterals (SVP) Estimates and Projections (2015-2026)
2.4.4 Japan Small Volume Parenterals (SVP) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Small Volume Parenterals (SVP) Estimates and Projections (2015-2026)
2.4.6 India Small Volume Parenterals (SVP) Estimates and Projections (2015-2026)
3 Global Small Volume Parenterals (SVP) Competition Landscape by Players
3.1 Global Top Small Volume Parenterals (SVP) Players by Sales (2015-2020)
3.2 Global Top Small Volume Parenterals (SVP) Players by Revenue (2015-2020)
3.3 Global Small Volume Parenterals (SVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Volume Parenterals (SVP) as of 2019)
3.4 Global Small Volume Parenterals (SVP) Average Price by Company (2015-2020)
3.5 Manufacturers Small Volume Parenterals (SVP) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Small Volume Parenterals (SVP) Players (Opinion Leaders)
4 Global Small Volume Parenterals (SVP) Market Size by Type
4.1 Global Small Volume Parenterals (SVP) Historic Market Review by Type (2015-2020)
4.1.1 Global Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
4.1.2 Global Small Volume Parenterals (SVP) Revenue Market Share by Type (2015-2020)
4.1.3 Global Small Volume Parenterals (SVP) Price by Type (2014-2020)
4.2 Global Small Volume Parenterals (SVP) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Small Volume Parenterals (SVP) Sales Forecast by Type (2021-2026)
4.2.2 Global Small Volume Parenterals (SVP) Revenue Forecast by Type (2021-2026)
4.2.3 Global Small Volume Parenterals (SVP) Price Forecast by Type (2021-2026)
5 Global Small Volume Parenterals (SVP) Market Size by Application
5.1 Global Small Volume Parenterals (SVP) Historic Market Review by Application (2015-2020)
5.1.1 Global Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)
5.1.2 Global Small Volume Parenterals (SVP) Revenue Market Share by Application (2015-2020)
5.1.3 Global Small Volume Parenterals (SVP) Price by Application (2015-2020)
5.2 Global Small Volume Parenterals (SVP) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Small Volume Parenterals (SVP) Sales Forecast by Application (2021-2026)
5.2.2 Global Small Volume Parenterals (SVP) Revenue Forecast by Application (2021-2026)
5.2.3 Global Small Volume Parenterals (SVP) Price Forecast by Application (2021-2026)

3 North America Small Volume Parenterals (SVP) Market Facts & Figures
3.2 North America Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
3.3 North America Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
3.4 North America Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)

4 Europe Small Volume Parenterals (SVP) Market Facts & Figures
4.2 Europe Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
4.3 Europe Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
4.4 Europe Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)

5 China Small Volume Parenterals (SVP) Market Facts & Figures
5.2 China Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
5.3 China Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
5.4 China Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)

6 Japan Small Volume Parenterals (SVP) Market Facts & Figures
6.2 Japan Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
6.3 Japan Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
6.4 Japan Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)

7 Southeast Asia Small Volume Parenterals (SVP) Market Facts & Figures
7.2 Southeast Asia Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)

8 India Small Volume Parenterals (SVP) Market Facts & Figures
8.2 India Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
8.3 India Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
8.4 India Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Small Volume Parenterals (SVP) Business
12.1 Allergan
12.1.1 Allergan Small Volume Parenterals (SVP) Corporation Information
12.1.2 Allergan Small Volume Parenterals (SVP) Business Overview and Total Revenue
12.1.3 Allergan Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Allergan Small Volume Parenterals (SVP) Products Offered
12.1.5 Allergan Recent Development
12.2 Bayer
12.2.1 Bayer Small Volume Parenterals (SVP) Corporation Information
12.2.2 Bayer Small Volume Parenterals (SVP) Business Overview and Total Revenue
12.2.3 Bayer Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Small Volume Parenterals (SVP) Products Offered
12.2.5 Bayer Recent Development
12.3 GSK
12.3.1 GSK Small Volume Parenterals (SVP) Corporation Information
12.3.2 GSK Small Volume Parenterals (SVP) Business Overview and Total Revenue
12.3.3 GSK Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GSK Small Volume Parenterals (SVP) Products Offered
12.3.5 GSK Recent Development
12.4 J&J
12.4.1 J&J Small Volume Parenterals (SVP) Corporation Information
12.4.2 J&J Small Volume Parenterals (SVP) Business Overview and Total Revenue
12.4.3 J&J Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 J&J Small Volume Parenterals (SVP) Products Offered
12.4.5 J&J Recent Development
12.5 Pfizer
12.5.1 Pfizer Small Volume Parenterals (SVP) Corporation Information
12.5.2 Pfizer Small Volume Parenterals (SVP) Business Overview and Total Revenue
12.5.3 Pfizer Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Small Volume Parenterals (SVP) Products Offered
12.5.5 Pfizer Recent Development
12.6 Teva
12.6.1 Teva Small Volume Parenterals (SVP) Corporation Information
12.6.2 Teva Small Volume Parenterals (SVP) Business Overview and Total Revenue
12.6.3 Teva Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Small Volume Parenterals (SVP) Products Offered
12.6.5 Teva Recent Development
12.7 Novartis
12.7.1 Novartis Small Volume Parenterals (SVP) Corporation Information
12.7.2 Novartis Small Volume Parenterals (SVP) Business Overview and Total Revenue
12.7.3 Novartis Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novartis Small Volume Parenterals (SVP) Products Offered
12.7.5 Novartis Recent Development

13 Small Volume Parenterals (SVP) Manufacturing Cost Analysis
13.1 Small Volume Parenterals (SVP) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Small Volume Parenterals (SVP)
13.4 Small Volume Parenterals (SVP) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Small Volume Parenterals (SVP) Distributors List
14.3 Small Volume Parenterals (SVP) Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Small Volume Parenterals (SVP) Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Small Volume Parenterals (SVP) Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Small Volume Parenterals (SVP) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Small Volume Parenterals (SVP) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Small Volume Parenterals (SVP) Players to Combat Covid-19 Impact
Table 8. Global Market Small Volume Parenterals (SVP) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Small Volume Parenterals (SVP) Sales (K Doses) by Region (2015-2020)
Table 10. Global Small Volume Parenterals (SVP) Sales Market Share by Region (2015-2020)
Table 11. Global Small Volume Parenterals (SVP) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Small Volume Parenterals (SVP) Revenue Share by Region (2015-2020)
Table 13. Global Small Volume Parenterals (SVP) Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Small Volume Parenterals (SVP) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Small Volume Parenterals (SVP) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Small Volume Parenterals (SVP) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Small Volume Parenterals (SVP) (K Doses) of Key Companies (2015-2020)
Table 18. Global Small Volume Parenterals (SVP) Sales Share by Company (2015-2020)
Table 19. Global Small Volume Parenterals (SVP) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Small Volume Parenterals (SVP) Revenue Share by Company (2015-2020)
Table 21. Global Small Volume Parenterals (SVP) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Volume Parenterals (SVP) as of 2019)
Table 22. Global Small Volume Parenterals (SVP) Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Small Volume Parenterals (SVP) Manufacturing Sites and Area Served
Table 24. Manufacturers Small Volume Parenterals (SVP) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Small Volume Parenterals (SVP) Players
Table 27. Global Small Volume Parenterals (SVP) Sales (K Doses) by Type (2015-2020)
Table 28. Global Small Volume Parenterals (SVP) Sales Share by Type (2015-2020)
Table 29. Global Small Volume Parenterals (SVP) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Small Volume Parenterals (SVP) Price (K Doses) by Type (2015-2020)
Table 31. Global Small Volume Parenterals (SVP) Sales Share by Type (2021-2026)
Table 32. Global Small Volume Parenterals (SVP) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Small Volume Parenterals (SVP) Revenue Share by Type (2021-2026)
Table 34. Global Small Volume Parenterals (SVP) Price (K Doses) by Type (2021-2026)
Table 35. Global Small Volume Parenterals (SVP) Sales (K Doses) by Application (2015-2020)
Table 36. Global Small Volume Parenterals (SVP) Sales Share by Application (2015-2020)
Table 37. Global Small Volume Parenterals (SVP) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Small Volume Parenterals (SVP) Price (K Doses) by Application (2015-2020)
Table 39. Global Small Volume Parenterals (SVP) Sales (K Doses) by Application (2021-2026)
Table 40. Global Small Volume Parenterals (SVP) Sales Share by Application (2021-2026)
Table 41. Global Small Volume Parenterals (SVP) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Small Volume Parenterals (SVP) Revenue Share by Application (2021-2026)
Table 43. Global Small Volume Parenterals (SVP) Price (K Doses) by Application (2021-2026)
Table 44. United States Small Volume Parenterals (SVP) Sales (K Doses) by Company (2015-2020)
Table 45. United States Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
Table 46. United States Small Volume Parenterals (SVP) Sales (K Doses) by Type (2015-2020)
Table 47. United States Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
Table 48. United States Small Volume Parenterals (SVP) Sales (K Doses) by Application (2015-2020)
Table 49. United States Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)
Table 50. Europe Small Volume Parenterals (SVP) Sales (K Doses) by Company (2015-2020)
Table 51. Europe Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
Table 52. Europe Small Volume Parenterals (SVP) Sales (K Doses) by Type (2015-2020)
Table 53. Europe Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
Table 54. Europe Small Volume Parenterals (SVP) Sales (K Doses) by Application (2015-2020)
Table 55. Europe Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
Table 56. China Small Volume Parenterals (SVP) Sales (K Doses) by Company (2015-2020)
Table 57. China Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
Table 58. China Small Volume Parenterals (SVP) Sales (K Doses) by Type (2015-2020)
Table 59. China Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
Table 60. China Small Volume Parenterals (SVP) Sales (K Doses) by Application (2015-2020)
Table 61. China Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)
Table 62. Japan Small Volume Parenterals (SVP) Sales (K Doses) by Company (2015-2020)
Table 63. Japan Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
Table 64. Japan Small Volume Parenterals (SVP) Sales (K Doses) by Type (2015-2020)
Table 65. Japan Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
Table 66. Japan Small Volume Parenterals (SVP) Sales (K Doses) by Application (2015-2020)
Table 67. Japan Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Small Volume Parenterals (SVP) Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Small Volume Parenterals (SVP) Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Small Volume Parenterals (SVP) Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)
Table 74. India Small Volume Parenterals (SVP) Sales (K Doses) by Company (2015-2020)
Table 75. India Small Volume Parenterals (SVP) Sales Market Share by Company (2015-2020)
Table 76. India Small Volume Parenterals (SVP) Sales (K Doses) by Type (2015-2020)
Table 77. India Small Volume Parenterals (SVP) Sales Market Share by Type (2015-2020)
Table 78. India Small Volume Parenterals (SVP) Sales (K Doses) by Application (2015-2020)
Table 79. India Small Volume Parenterals (SVP) Sales Market Share by Application (2015-2020)
Table 80. Allergan Corporation Information
Table 81. Allergan Description and Business Overview
Table 82. Allergan Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Allergan Small Volume Parenterals (SVP) Product
Table 84. Allergan Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Bayer Small Volume Parenterals (SVP) Product
Table 89. Bayer Recent Development
Table 90. GSK Corporation Information
Table 91. GSK Description and Business Overview
Table 92. GSK Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. GSK Small Volume Parenterals (SVP) Product
Table 94. GSK Recent Development
Table 95. J&J Corporation Information
Table 96. J&J Description and Business Overview
Table 97. J&J Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. J&J Small Volume Parenterals (SVP) Product
Table 99. J&J Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Pfizer Small Volume Parenterals (SVP) Product
Table 104. Pfizer Recent Development
Table 105. Teva Corporation Information
Table 106. Teva Description and Business Overview
Table 107. Teva Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Teva Small Volume Parenterals (SVP) Product
Table 109. Teva Recent Development
Table . Novartis Corporation Information
Table . Novartis Description and Business Overview
Table . Novartis Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Novartis Small Volume Parenterals (SVP) Product
Table . Novartis Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Small Volume Parenterals (SVP) Distributors List
Table 118. Small Volume Parenterals (SVP) Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Small Volume Parenterals (SVP) Product Picture
Figure 2. Global Small Volume Parenterals (SVP) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Small Volume Parenterals (SVP) Market Share by Application in 2020 & 2026
Figure 6. Local Anesthetics Examples
Figure 7. Vaccines Examples
Figure 8. Other Examples
Figure 9. Global Small Volume Parenterals (SVP) Sales (K Doses) Growth Rate (2015-2026)
Figure 10. Global Small Volume Parenterals (SVP) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Small Volume Parenterals (SVP) Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 12. Global Small Volume Parenterals (SVP) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Small Volume Parenterals (SVP) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Small Volume Parenterals (SVP) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Small Volume Parenterals (SVP) Sales (K Doses) Growth Rate (2015-2026)
Figure 16. Europe Small Volume Parenterals (SVP) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Small Volume Parenterals (SVP) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Small Volume Parenterals (SVP) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Small Volume Parenterals (SVP) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Small Volume Parenterals (SVP) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Small Volume Parenterals (SVP) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Small Volume Parenterals (SVP) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Small Volume Parenterals (SVP) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Small Volume Parenterals (SVP) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Small Volume Parenterals (SVP) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Small Volume Parenterals (SVP) Players Market Share by Revenue in Small Volume Parenterals (SVP) 2015 & 2019
Figure 27. Small Volume Parenterals (SVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Small Volume Parenterals (SVP) Revenue Share by Type (2015-2020)
Figure 29. Global Small Volume Parenterals (SVP) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Small Volume Parenterals (SVP) Revenue Share by Application (2015-2020)
Figure 31. Global Small Volume Parenterals (SVP) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Small Volume Parenterals (SVP) Sales Market Share by Type in 2019
Figure 33. United States Small Volume Parenterals (SVP) Sales Market Share by Type in 2019
Figure 34. Europe Small Volume Parenterals (SVP) Sales Market Share by Company in 2019
Figure 35. Europe Small Volume Parenterals (SVP) Sales Market Share by Type in 2019
Figure 36. Europe Small Volume Parenterals (SVP) Sales Market Share by Application in 2019
Figure 37. China Small Volume Parenterals (SVP) Sales Market Share by Company in 2019
Figure 38. China Small Volume Parenterals (SVP) Sales Market Share by Type in 2019
Figure 39. China Small Volume Parenterals (SVP) Sales Market Share by Application in 2019
Figure 40. Japan Small Volume Parenterals (SVP) Sales Market Share by Company in 2019
Figure 41. Japan Small Volume Parenterals (SVP) Sales Market Share by Type in 2019
Figure 42. Japan Small Volume Parenterals (SVP) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Small Volume Parenterals (SVP) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Small Volume Parenterals (SVP) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Small Volume Parenterals (SVP) Sales Market Share by Application in 2019
Figure 46. India Small Volume Parenterals (SVP) Sales Market Share by Company in 2019
Figure 47. India Small Volume Parenterals (SVP) Sales Market Share by Type in 2019
Figure 48. India Small Volume Parenterals (SVP) Sales Market Share by Application in 2019
Figure 49. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. J&J Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Small Volume Parenterals (SVP)
Figure 58. Manufacturing Process Analysis of Small Volume Parenterals (SVP)
Figure 59. Small Volume Parenterals (SVP) Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed